United States · 
Who invested in SyntaxBio?
SyntaxBio's investors include DCVC, Draper Associates, Illumina Ventures and Mayo Clinic.
2026
$856KGrant$14MSeries A
United States · Series A startup
Who invested in SyntaxBio
Funding summaryUpdated 26 Oct 2026
$15Mraised across 2 rounds since 2025, from 3 sources
$856KGrant$14MSeries A
- Latest round
- Series A, $14MJul 2026
- Step-upi
- 16.8×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $856K Dec 2025
- Biggest round
- $14M Series A · Jul 2026
- Between rounds
- 7 months from the last two
The rounds
- Jul 2026Series A$14M1 new3 returning
Reported by Firms' own news pages and 1 other
- Dec 2025
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about SyntaxBio
How much has SyntaxBio raised?
SyntaxBio has raised $15M across 2 rounds since 2025.
When did SyntaxBio last raise?
SyntaxBio's most recent round was a Series A of $14M in Jul 2026.
What was SyntaxBio's biggest round?
Its most recent round, $14M in Jul 2026, is also its largest on record.
Who backed SyntaxBio first?
SyntaxBio's first round on record, in Dec 2025, was backed by DCVC, Draper Associates and Illumina Ventures.
What stage is SyntaxBio at?
SyntaxBio's latest named round is a Series A, in Jul 2026.
Where is SyntaxBio based?
SyntaxBio is based in the United States.
Companies like SyntaxBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.